SCGB3A2 and pulmonary fibrosis: In a previous study, exogenously administered human recombinant SCGB3A2 showed a similar effect in suppressing BLM-induced pulmonary fibrosis using mouse model, suggesting that human SCGB3A2 most likely suppresses pulmonary fibrosis in humans [18].